CN103223155A - Medicament for treating postpartum hemorrhage - Google Patents
Medicament for treating postpartum hemorrhage Download PDFInfo
- Publication number
- CN103223155A CN103223155A CN2013101848333A CN201310184833A CN103223155A CN 103223155 A CN103223155 A CN 103223155A CN 2013101848333 A CN2013101848333 A CN 2013101848333A CN 201310184833 A CN201310184833 A CN 201310184833A CN 103223155 A CN103223155 A CN 103223155A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- herba
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating postpartum hemorrhage, which is prepared from the following components in certain parts by weight: figwort, cornel, Acorus gramineus, ephedra, clove, saururus chinensis, red tangerine peel, rhizoma sparganii, rhubarb, equisetum, eupatorium, rhizoma anemarrhenae, tuckahoe, dried orange peel, moutan bark, eucommia, kudzu root, heracleum hemsleyanum michaux, Rhizoma Zedoariae, selfheal, Alpinia katsumadai, radix curcumae, myrrh, Curculigo orchioides, folium artemisiae argyi, flower of silktree, rhiaoma iridis tectori, acanthopanax bark, rangooncreeper fruit, emblic leafflower fruit, Fructus Forsythiae, immature bitter orange, rhizoma alismatis, gromwell, Ligotidis Herba, Phytolacca acinosa, rose, magnolia flower, Herba Polygalae Japonicae, radix sileris, dried ginger, seville orange flower, murraya jasminorage, aspongopus, rhizoma pleionis, morinda root, pomegranate rind, morning glory seed, gerba pyrolae and marsdeniae tenacissimae caulis. The medicament provided by the invention has the advantages of accessible raw materials and exact curative effect; and tests prove that the medicament is high in effective rate and low in cost.
Description
Technical field
The present invention relates to the department of obstetrics and gynecology field, relate in particular to a kind of medicine for the treatment of postpartum hemorrhage.
Background technology
Postpartum hemorrhage also is the first reason of the current pregnant and lying-in women's of causing clinical death as one of the most serious term complication.At present clinically generally adopt oxytocin to prevent and control, though effect is better, because oxytocin must drug administration by injection, and individual sensitivity differs greatly, and therefore has inconvenience when actual therapeutic is used.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of postpartum hemorrhage.
In order to realize purpose of the present invention, the invention provides a kind of medicine for the treatment of postpartum hemorrhage, it is to be made by following substances in parts by weight: 10 parts of Radix Scrophulariaes, 10 parts of Fructus Corni, 20 parts of Rhizoma Acori Graminei, 20 parts in Herba Ephedrae, 8 parts of Flos Caryophyllis, 25 parts of Rhizoma Saururi (Herba Saururi)s, tangerine 13 parts, 30 parts of rhizoma sparganic, 5 parts of Radix Et Rhizoma Rhei, 25 parts of Herba Equiseties Hiemalis, 15 parts of Herba Eupatoriis, 25 parts of the Rhizoma Anemarrhenaes, 40 parts in Poria, 20 parts of Pericarpium Citri Reticulataes, 10 parts of Cortex Moutans, 15 parts of the Cortexs Eucommiae, 20 parts of Radix Puerariaes, 10 parts of Radix Angelicae Pubescentiss, 15 parts of Rhizoma Curcumae, 30 parts of Spica Prunellaes, 15 parts of Semen Alpiniae Katsumadai, 30 parts of Radix Curcumaes, 20 parts of Myrrhas, 15 parts of Rhizoma Curculiginises, 35 parts of Folium Artemisiae Argyis, 25 parts of Flos Albiziaes, 25 parts of Rhizoma Belamcandaes, 26 parts of Cortex Acanthopanciss, 15 parts of Fructus Quisqualis, 25 parts of Fructus Phyllanthis, 30 parts of Fructus Forsythiaes, 15 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Alismatis, 10 parts of Radix Arnebiae (Radix Lithospermi)s, 5 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 10 parts of Radix Phytolaccaes, 10 parts of Flos Rosae Rugosaes, 20 parts of Flos Magnoliaes, 10 parts of Herba Polygalae Japonicae, 25 parts of Radix Saposhnikoviaes, 25 parts of Rhizoma Zingiberiss, 10 parts of CitrusaurantiumL.Var.amara Engl.s, 45 parts of Folium Et Cacumen Murrayae, 60 parts of Aspongopuss, 50 parts of Pseudobulbus Cremastrae Seu Pleioness, 50 parts of Radix Morindae Officinaliss, 70 parts of Pericarpium Granatis, 40 parts of Semen Pharbitidiss, 50 parts of 35 parts of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes.
Preferably, medicine of the present invention can be made tablet, dispersible tablet, capsule or powder.
Raw material of the present invention is easy to get, determined curative effect, and through evidence effective percentage height, cost is low.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get Radix Scrophulariae 10 grams, Fructus Corni 10 grams, Rhizoma Acori Graminei 20 grams, Herba Ephedrae 20 grams, Flos Caryophylli 8 grams, Rhizoma Saururi (Herba Saururi) 25 grams, tangerine 13 grams, rhizoma sparganic 30 grams, Radix Et Rhizoma Rhei 5 grams, Herba Equiseti Hiemalis's 25 grams, Herba Eupatorii 15 grams, the Rhizoma Anemarrhenae 25 grams, Poria 40 grams, Pericarpium Citri Reticulatae 20 grams, Cortex Moutan 10 grams, the Cortex Eucommiae 15 grams, Radix Puerariae 20 grams, Radix Angelicae Pubescentis 10 grams, Rhizoma Curcumae 15 grams, Spica Prunellae 30 grams, Semen Alpiniae Katsumadai 15 grams, Radix Curcumae 30 grams, Myrrha 20 grams, Rhizoma Curculiginis 15 grams, Folium Artemisiae Argyi 35 grams, Flos Albiziae 25 grams, Rhizoma Belamcandae 25 grams, Cortex Acanthopancis 26 grams, Fructus Quisqualis 15 grams, Fructus Phyllanthi 25 grams, Fructus Forsythiae 30 grams, Fructus Aurantii Immaturus 15 grams, Rhizoma Alismatis 30 grams, Radix Arnebiae (Radix Lithospermi) 10 grams, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.) 5 grams, Radix Phytolaccae 10 grams, Flos Rosae Rugosae 10 grams, Flos Magnoliae 20 grams, Herba Polygalae Japonicae 10 grams, Radix Saposhnikoviae 25 grams, Rhizoma Zingiberis 25 grams, CitrusaurantiumL.Var.amara Engl. 10 grams, Folium Et Cacumen Murrayae 45 grams, Aspongopus 60 grams, Pseudobulbus Cremastrae Seu Pleiones 50 grams, Radix Morindae Officinalis 50 grams, Pericarpium Granati 70 grams, Semen Pharbitidis 40 grams, Herba Pyrolae 35 grams and Caulis Marsdeniae Tenacissimae 50 grams, pulverize, cross 100 mesh sieves, add sucrose 250 grams then, mixing is packed in 100 bags promptly.
Experimental example
Selection is through drug induced abortion and satisfy following condition person and include investigation in: menolipsis≤49 day, age≤40 year old, healthy, no intrauterine device, before the medicine stream routine blood test, liver function detect normal, the urine HCG positive, it is in utero pregnant that B ultrasonic confirms, can follow up a case by regular visits to.Choose patient's 60 examples that meet above-mentioned condition, minimum 24 years old of age, maximum 36 years old, 27.3 years old mean age.
Use the powder that makes among the embodiment 1 to treat, wherein one day 2 times, each one bag, 5 days is 1 course of treatment.Inactive other drug during the treatment.
Criterion of therapeutical effect
Recovery from illness: clinical symptoms, sign all disappear, lab testing urine pregnancy tests feminine gender, and ultrasound diagnosis belongs to normal uterus adnexa ultrasonogram.Take a turn for the better: clinical symptoms, sign disappear substantially, but do not do urine pregnancy tests and ultrasound diagnosis.Do not heal: clinical symptoms, sign are not improved.
Therapeutic outcome
Described 60 routine patients clinical symptoms, sign after treatment all disappear, lab testing urine pregnancy tests feminine gender, and ultrasound diagnosis belongs to normal uterus adnexa ultrasonogram, all meets the standard of recovery from illness.And do not observe tangible untoward reaction.
After this in 1 month, all the patient is followed up a case by regular visits to weekly, found that recurrence does not all appear in all patients.
Claims (2)
1. a medicine for the treatment of postpartum hemorrhage is characterized in that it is to be made by following substances in parts by weight: 10 parts of Radix Scrophulariaes, 10 parts of Fructus Corni, 20 parts of Rhizoma Acori Graminei, 20 parts in Herba Ephedrae, 8 parts of Flos Caryophyllis, 25 parts of Rhizoma Saururi (Herba Saururi)s, tangerine 13 parts, 30 parts of rhizoma sparganic, 5 parts of Radix Et Rhizoma Rhei, 25 parts of Herba Equiseties Hiemalis, 15 parts of Herba Eupatoriis, 25 parts of the Rhizoma Anemarrhenaes, 40 parts in Poria, 20 parts of Pericarpium Citri Reticulataes, 10 parts of Cortex Moutans, 15 parts of the Cortexs Eucommiae, 20 parts of Radix Puerariaes, 10 parts of Radix Angelicae Pubescentiss, 15 parts of Rhizoma Curcumae, 30 parts of Spica Prunellaes, 15 parts of Semen Alpiniae Katsumadai, 30 parts of Radix Curcumaes, 20 parts of Myrrhas, 15 parts of Rhizoma Curculiginises, 35 parts of Folium Artemisiae Argyis, 25 parts of Flos Albiziaes, 25 parts of Rhizoma Belamcandaes, 26 parts of Cortex Acanthopanciss, 15 parts of Fructus Quisqualis, 25 parts of Fructus Phyllanthis, 30 parts of Fructus Forsythiaes, 15 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Alismatis, 10 parts of Radix Arnebiae (Radix Lithospermi)s, 5 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 10 parts of Radix Phytolaccaes, 10 parts of Flos Rosae Rugosaes, 20 parts of Flos Magnoliaes, 10 parts of Herba Polygalae Japonicae, 25 parts of Radix Saposhnikoviaes, 25 parts of Rhizoma Zingiberiss, 10 parts of CitrusaurantiumL.Var.amara Engl.s, 45 parts of Folium Et Cacumen Murrayae, 60 parts of Aspongopuss, 50 parts of Pseudobulbus Cremastrae Seu Pleioness, 50 parts of Radix Morindae Officinaliss, 70 parts of Pericarpium Granatis, 40 parts of Semen Pharbitidiss, 50 parts of 35 parts of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes.
2. the medicine of treatment postpartum hemorrhage according to claim 1 is characterized in that described medicine can make tablet, dispersible tablet, capsule or powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310184833.3A CN103223155B (en) | 2013-05-20 | 2013-05-20 | Medicament for treating postpartum hemorrhage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310184833.3A CN103223155B (en) | 2013-05-20 | 2013-05-20 | Medicament for treating postpartum hemorrhage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103223155A true CN103223155A (en) | 2013-07-31 |
| CN103223155B CN103223155B (en) | 2014-07-09 |
Family
ID=48833951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310184833.3A Expired - Fee Related CN103223155B (en) | 2013-05-20 | 2013-05-20 | Medicament for treating postpartum hemorrhage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103223155B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103239700A (en) * | 2013-05-20 | 2013-08-14 | 黄慧 | Medicament for treating rheumatism |
| CN103251919A (en) * | 2013-06-03 | 2013-08-21 | 史秀华 | Medicine for treating upper respiratory tract infections |
| CN103251918A (en) * | 2013-06-03 | 2013-08-21 | 袁梅 | Medicine for treating gastrointestinal tract diseases |
| CN103285355A (en) * | 2013-06-14 | 2013-09-11 | 孟凡美 | Medicine for treating calculi in urinary system |
| CN104758619A (en) * | 2015-04-20 | 2015-07-08 | 任红霞 | Medicine for treating postpartum hemorrhage |
| CN104771572A (en) * | 2015-03-30 | 2015-07-15 | 邵田 | Traditional Chinese medicinal preparation for treating postpartum haemostasis, and preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998634A (en) * | 2006-01-13 | 2007-07-18 | 李晓华 | Traditional Chinese medicine composition for preventing postpartum weakness type cold and its preparing method |
| CN101032618A (en) * | 2007-04-09 | 2007-09-12 | 武传中 | Chinese traditional medicine for curing late puerperal hemorrhage |
-
2013
- 2013-05-20 CN CN201310184833.3A patent/CN103223155B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998634A (en) * | 2006-01-13 | 2007-07-18 | 李晓华 | Traditional Chinese medicine composition for preventing postpartum weakness type cold and its preparing method |
| CN101032618A (en) * | 2007-04-09 | 2007-09-12 | 武传中 | Chinese traditional medicine for curing late puerperal hemorrhage |
Non-Patent Citations (1)
| Title |
|---|
| 李晓洁: "加味生化汤在产后出血中的应用", 《吉林医学》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103239700A (en) * | 2013-05-20 | 2013-08-14 | 黄慧 | Medicament for treating rheumatism |
| CN103251919A (en) * | 2013-06-03 | 2013-08-21 | 史秀华 | Medicine for treating upper respiratory tract infections |
| CN103251918A (en) * | 2013-06-03 | 2013-08-21 | 袁梅 | Medicine for treating gastrointestinal tract diseases |
| CN103285355A (en) * | 2013-06-14 | 2013-09-11 | 孟凡美 | Medicine for treating calculi in urinary system |
| CN103285355B (en) * | 2013-06-14 | 2015-05-13 | 孟凡美 | Medicine for treating calculi in urinary system |
| CN104771572A (en) * | 2015-03-30 | 2015-07-15 | 邵田 | Traditional Chinese medicinal preparation for treating postpartum haemostasis, and preparation method |
| CN104771572B (en) * | 2015-03-30 | 2018-05-18 | 邵田 | Chinese medicine preparation for postpartum hemostasis and preparation method thereof |
| CN104758619A (en) * | 2015-04-20 | 2015-07-08 | 任红霞 | Medicine for treating postpartum hemorrhage |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103223155B (en) | 2014-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103223155B (en) | Medicament for treating postpartum hemorrhage | |
| CN101642529B (en) | Preparation capable of treating diabetes | |
| CN101584797A (en) | Application of traditional Chinese medicine composition in preparing medicament for treating climacteric syndrome | |
| CN102188583A (en) | Traditional Chinese medicine for treating infertility | |
| CN101780160A (en) | Traditional Chinese medicine preparation for treating gynecological disease and preparation method thereof | |
| CN101214315B (en) | Medicament for preventing and treating gynaecologic hemorrhage and preparation thereof | |
| CN102120020B (en) | Medicinal composition for treating hyperplastic diseases of breast and hysteromyoma and preparation method thereof | |
| CN106362104A (en) | Pharmaceutical composition for treating polycystic ovary syndrome in adolescence | |
| CN102526566A (en) | Chinese medicine preparation for treating hysteromyoma and ovarian cyst and preparation method | |
| CN105617151A (en) | Powder boiling type traditional Chinese medicine antibacterial and anti-inflammatory agent, preparation method and applications thereof | |
| CN103356980A (en) | Medicament for treating afterpains | |
| CN104399050A (en) | Traditional Chinese medicine for treating postpartum hemorrhage | |
| CN103263650B (en) | Chinese medicament for conditioning female menstruation | |
| CN102008688B (en) | Medicament for treating periodic psychosis | |
| CN101375984A (en) | Chinese medicine for treating anovulatory infertility | |
| CN103251918A (en) | Medicine for treating gastrointestinal tract diseases | |
| CN103301415B (en) | Medicinal composition for preventing and treating intrauterine adhesion after induced abortion operation and application thereof | |
| CN105031597A (en) | Traditional Chinese medicine drug used for treating infertility and habitual abortion | |
| CN103349760A (en) | Medicine for treating colporrhagia after abortion | |
| CN102772730A (en) | Medicine composition for treating ectopic pregnancy | |
| CN102698064A (en) | Medicament for treating climacteric syndrome | |
| CN106309636B (en) | Pharmaceutical composition for uterine bleeding | |
| CN103330929B (en) | Medicine for curing female infertility and preparation method thereof | |
| CN104888200A (en) | Chinese medicine coat containing capsule granule for promoting insulin microcirculation | |
| CN105250952B (en) | A kind of Chinese medicine composition for treating uterus adenomyosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140709 Termination date: 20150520 |
|
| EXPY | Termination of patent right or utility model |